ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
COVID vaccines

China and U.S. share tech in ASEAN for vaccine diplomacy edge

Drugmakers test new COVID-19 shots in region with eye on local production

A healthcare worker in Jakarta holds up a vial of the Sinopharm vaccine. Chinese and U.S. companies are conducting clinical trials for new alternatives in Indonesia.   © Reuters
KOYA JIBIKI and TOMOYA ONISHI, Nikkei staff writers | Indonesia

JAKARTA/HANOI -- Vaccine diplomacy by China and the U.S. has entered a new stage as their drugmakers transfer technology to players in Southeast Asia to kick-start local production.

Read Next

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more

By continuing to browse this website, you accept cookies which are used for several reasons such as personalizing content/ads and analyzing how this website is used. Please review our Cookie Policy to learn how you can update your cookie settings.

Accept & Continue Close